Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

Projects / Programmes source: ARIS

Phenotype, genotype and epidemiological properties of bacteria Chlamydia pneumoniae

Edit
Research activity

Code Science Field Subfield
3.01.00  Medical sciences  Microbiology and immunology   

Code Science Field
B230  Biomedical sciences  Microbiology, bacteriology, virology, mycology 
Keywords
Chlamydia pneumoniae, pneumonia, atherosclerosis, DNA, oligonucleotides, gene, epidemiology, diagnosis
Evaluation (rules)
source: COBISS
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Researchers (7)
no. Code Name and surname Research area Role Period No. of publications
1.  19591  Done Golubovski  Microbiology and immunology  Researcher  2001 - 2002  8 
2.  05381  PhD Darja Keše  Microbiology and immunology  Head  2002 - 2004  260 
3.  18064  Danica Krečič    Researcher  2002 - 2004  0 
4.  12555  PhD Jošt Kuret  Microbiology and immunology  Researcher  2001 - 2002  27 
5.  05382  PhD Saša Simčič  Microbiology and immunology  Researcher  2002 - 2004  148 
6.  03287  PhD Marjeta Zorc  Cardiovascular system  Researcher  2002 - 2004  173 
7.  15001  PhD Anamarija Zore  Microbiology and immunology  Researcher  2002 - 2004  204 
Organisations (1)
no. Code Research organisation City Registration number No. of publications
1.  0381  University of Ljubljana, Faculty of Medicine  Ljubljana  1627066  45,085 
Abstract
Chlamydia pneumoniae is so called "emerging pathogen" which patogenicity is still unknown and is so the subject of many researches studying worldwide. C. pneumoniae is recognized as an important respiratory pathogen. Studies have also associated this organism with atherosclerotic heart disease. In our study we will determinate the prevalence rates of C. pneumoniae infections in our patients with community acquired pneumonia and in patients with atherosclerosis with the use of serological test and the methods of molecular biology. With the analysis of different DNA C. pneumoniae fragments we will study if it is possible that distinct clinical disease syndromes such as respiratory tract infections or atherosclerosis are associated with different C. pneumoniae serovars or genotypes. The results will be important for understanding the epidemiology and the pathogenicity of C. pneumoniae and will contribute to establih the standardization of the laboratory diagnostic procedures.
Confirmation required
Views history
Favourite